Babesia ADN-PCR (BABPCR)* |
480 |
470 |
1510 |
Babesia ADN-PCR in capusa (BABPCZ)* |
330 |
323 |
2276 |
Babesia microti Ac IgG (BABGI)* |
180 |
174 |
5802 |
Barbiturice (BAR) in urina - screening** |
106 |
102 |
5736 |
Barbiturice in ser (BARB)* |
155 |
150 |
2018 |
Bartonella henselae - Ac IgG si IgM (KATZE)* |
220 |
215 |
4402 |
Bartonella henselae ADN-PCR in tesut biopsie/punctie (BAHPCR)* |
606 |
593 |
2335 |
Bartonella henselae si quintana Ac IgG si IgM (BART)* |
352 |
344 |
4403 |
BCL1/ICH,t(11,14)(q13;q32) - FISH* |
995 |
995 |
5698 |
BCL1/ICH,t(11,14)(q13;q32) - PCR* |
485 |
485 |
5699 |
BCR/ABL - t(;22) FISH* |
800 |
800 |
4454 |
BCR/ABL - t(9;22) cuantificare (P190, P210), RT-PCR* |
800 |
800 |
4695 |
BDNF-factor neurotrofic derivat din creier (BDNF)* |
209 |
204 |
2698 |
Benzen (BZOL)* |
390 |
382 |
5833 |
Benzi oligoclonale si Index IgG LCR/ser, Imunofixare (OLIGO)* |
280 |
274 |
5676 |
Benzodiazepine (BZO) in urina - screening** |
111 |
107 |
3208 |
Benzodiazepine in ser (BENZ)* |
496 |
486 |
2017 |
Beriliu in urina (BERU)* |
428 |
419 |
2226 |
Beta 2 Microglobulina |
77 |
73 |
1550 |
Beta 2 Microglobulina in LCR (B2MIL)* |
95 |
91 |
2710 |
Beta 2 Microglobulina urinara (B2MIU)* |
105 |
101 |
1804 |
Beta Amiloid raport 42/40 in LCR (AMYLIQ)* |
374 |
366 |
2713 |
Beta caroten (CARO)* |
176 |
170 |
1591 |
Beta Galactocerebrozidaza (BGALCB)* |
220 |
215 |
2999 |
Beta Glucuronidaza, inclusiv Beta Galactozidaza* |
385 |
377 |
2257 |
Beta HCG-marker tumoral in lichid de punctie (HCGTP)* |
92 |
88 |
4939 |
Beta Thalassemia, screening panel HBB - Hot Spot* |
1300 |
1300 |
5511 |
Beta-2-Transferina (B2TNS)* |
396 |
388 |
3611 |
Beta-crosslaps (CTX)** |
66 |
63 |
1342 |
Beta-D-Glucan (BDGLU)* |
415 |
406 |
4348 |
Beta-defensina in materii fecale (BDEFST)* |
110 |
106 |
5107 |
Beta-hidroxibutirat (acid beta-hidroxibutiric) (HBUT)* |
150 |
145 |
5832 |
Bilirubina directa(conjugata) |
14 |
13 |
8 |
Bilirubina indirecta(neconjugata)** |
15 |
14 |
9 |
Bilirubina totala |
15 |
14 |
10 |
Biomarkeri pentru tumori solide - panel extins 500 gene - NGS* |
12000 |
12000 |
5648 |
Biopsia lichida - biomarkeri de ADN tumoral, panel de 52 de gene - mutatii, amplificari si rearanjari (translocatii si fuziuni) - secventiere NGS* |
10500 |
10500 |
5211 |
Biotinidaza - activitate (BIOTA)* |
325 |
318 |
5368 |
Biotinidaza din picatura de sange pe hartie-filtru (BIOT)* |
165 |
160 |
2373 |
Biperiden (BIPER)* |
400 |
392 |
4845 |
Bisfenol A in urina (BISPA)* |
428 |
419 |
4817 |
Bisoprolol (BISOP)* |
390 |
382 |
4648 |
BNP-NT-Propeptid |
160 |
155 |
1621 |
Boala Alzheimer - predispozitie genetica - gena PSEN1, secventiere* |
2200 |
2200 |
4674 |
Boala Alzheimer - predispozitie genetica - gena PSEN2, secventiere (PSEN2)* |
5600 |
5600 |
5296 |
Boala chistica renala (nefronoftizis) - screening 19 gene - secventiere* |
6800 |
6800 |
4673 |
Boala Creutzfeld Jacobs (E200K - PRNP) - secventiere* |
1500 |
1500 |
5531 |
Boala Creutzfeld Jacobs (PRNP) - secventiere* |
1600 |
1600 |
5530 |
Boala Danon - proteina membranara 2 asociata lizozomilor (LAMP2)* |
2310 |
2286 |
4885 |
Boala Danon (cardiomiopatie vacuolara si miopatie cu transmitere legata de X) - gena LAMP2 - secventiere* |
3500 |
3500 |
4884 |
Boala Fabry deficitul alpha-galactozidazei - etapa 1 secventierea genei GLA* |
3400 |
3400 |
3132 |
Boala Fabry deficitul alpha-galactozidazei - etapa 2 MLPA gena GLA* |
2200 |
2200 |
3133 |
Boala ficatului polichistic - panel complex de 6 gene - PLUS, SEQ, DEL/DUP (GA0201)* |
3600 |
3600 |
5475 |
Boala granulomatoasa cronica - panel complex de 8 gene - PLUS, SEQ, DEL/DUP (IM0601)* |
3600 |
3600 |
5447 |
Boala Hirschprung - panel complex de 15 gene - PLUS, SEQ, DEL/DUP (MA1801)* |
3600 |
3600 |
5472 |
Boala Niemann-Pick - tipulA/B - gena SMPD1 secventiere* |
1000 |
1000 |
5844 |
Boala Parkinson - panel 82 de gene - PLUS, SEQ, DEL/DUP (NE1501)* |
4600 |
4600 |
5432 |
Boala Parkinson cu debut timpuriu - panel de gene (PARK2, PARK6 (PINK1), PARK 7, PARK8 (LRRK2)) - secventiere NGS* |
4800 |
4800 |
4688 |
Boala Parkinson tip 2 - gena PARK2 - MLPA* |
2200 |
2200 |
5053 |
Boala Parkinson tip 2 - gena PARK2 - secventiere* |
1450 |
1450 |
5052 |
Boala Pelizaeus-Merzbacher - gena PLP1 - MLPA* |
1850 |
1850 |
5850 |
Boala Pompe - Boli cu stocare de glicogen (GAA) – secventiere* |
8000 |
8000 |
4842 |
Boala Pompe - Boli cu stocare de glicogen – MLPA* |
1800 |
1800 |
4843 |
Boala rinichiului polichistic - panel 10 gene - PLUS, SEQ, DEL/DUP (KI2101)* |
3600 |
3600 |
5047 |
Boala Stargardt - gena ABCA4-secventiere* |
14000 |
14000 |
3571 |
Boala Stargardt - gena CNGB3-secventiere* |
9500 |
9500 |
3572 |
Boala Stargardt - gena ELOVL4-secventiere* |
6000 |
6000 |
3573 |
Boala Tay Sachs - gena HEX-A - MLPA* |
1350 |
1350 |
5099 |
Boala Tay Sachs - gena HEX-A - secventiere si MLPA* |
5900 |
5900 |
5100 |
Boala Tay Sachs - gena HEX-A - secventiere* |
4850 |
4850 |
5098 |
Boala vonWillebrand - analiza exonului 28 - subtipurile 2A, 2B, 2M* |
1000 |
1000 |
3047 |
Boala vonWillebrand - analiza genei MLPA* |
2200 |
2200 |
3046 |
Boala vonWillebrand - secventierea genei* |
9200 |
9200 |
3045 |
Boala Waldenstorm, gena CXCR4 de rezistenta la Ibrutinib - secventiere* |
500 |
500 |
4722 |
Boala Wilson - analiza MLPA a genei ATP7B* |
2000 |
2000 |
3659 |
Boala Wilson - mutatia H1069Q in gena ATP7B* |
450 |
450 |
1597 |
Boala Wilson - secventierea genei ATP7B* |
12300 |
12300 |
3658 |
Boli lizozomale si mucopolizaharidoze - panel complex de 102 gene - PLUS, SEQ, DEL/DUP (ME1501)* |
4600 |
4600 |
5449 |
Boli metabolice ereditare - panel complex de 505 gene - PLUS, SEQ, DEL/DUP (ME0701)* |
5200 |
5200 |
5427 |
Boli oncologice hematologice si neoplazii ereditare - panel comprehensiv de 369 de gene - PLUS, SEQ, DEL/DUP (HE1401)* |
5200 |
5200 |
5463 |
Bor in sange (BVB)* |
439 |
430 |
5318 |
Bor in ser (B)* |
439 |
430 |
5317 |
Bordetella pertussis Ac IgA (BORAE)* |
95 |
91 |
1782 |
Bordetella pertussis Ac IgG (BORGE)* |
95 |
91 |
1783 |
Bordetella pertussis Ac IgM* |
125 |
121 |
5618 |
Bordetella pertussis ADN-PCR (BPEPCR)* |
287 |
281 |
1785 |
Bornaprine (BORNA)* |
400 |
392 |
4846 |
Borrelia Ac IgG** |
75 |
72 |
576 |
Borrelia Ac IgM** |
77 |
73 |
575 |
Borrelia ADN-PCR din LCR (LYMPCL)* |
440 |
431 |
1511 |
Borrelia ADN-PCR din lichid de punctie/aspirat (LYMPCR)* |
441 |
432 |
3258 |
Borrelia ADN-PCR in capusa (LYMPCZ)* |
365 |
357 |
2814 |
Borrelia burgdorferi IgG si IgM in LCR si ser cu indice de gradient (LYMAUS)* |
440 |
431 |
5490 |
Borrelia confirmare RN AT Imunoblot - IgG** |
190 |
184 |
2611 |
Borrelia confirmare RN AT Imunoblot - IgM** |
170 |
164 |
5346 |
Borrelia Limfocite CD3-CD57+ (LYDBO)* |
320 |
313 |
2735 |
BRCA + 16 GENES - panel 18 gene implicate in cancerul de san, ovar, endometru* |
2700 |
2700 |
4466 |
BRCA 2 - analiza unei mutatii familiale* |
1150 |
1150 |
4469 |
BRCA1 - analiza MLPA* |
950 |
950 |
3732 |
BRCA1, BRCA2 - analiza MLPA* |
2000 |
2000 |
5506 |
BRCA2 - analiza MLPA* |
950 |
950 |
3733 |
Brivaracetam (BRIVA)* |
400 |
392 |
4763 |
Brom in ser (BR)* |
120 |
116 |
2220 |
Bromocriptina (BRCRI)* |
400 |
392 |
4847 |
Brucella abortus IgG* |
110 |
106 |
4943 |
Brucella abortus IgM* |
95 |
91 |
4944 |
Brucella ADN-PCR in LCR (BRULIQ)* |
386 |
378 |
2744 |
Brucella spp. (canis, abortus, melitensis, suis) Ac IgG (BRUGE)* |
140 |
135 |
4941 |
Brucella spp. (canis, abortus, melitensis, suis) Ac IgM (BRUME)* |
140 |
135 |
4942 |
Buprenorfine (BUP) in urina - screening** |
106 |
102 |
5739 |